All posts tagged
Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs
Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO
Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq
New Combo Therapy for Type 2 Diabetes to Sweep Europe
Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.
Here are 12 Biotechs you need to know in Copenhagen – Skål!
Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
Giving new life to Sanofi’s annual €6.2Bn diabetes blockbuster Lantus
Labiotech UG, All Rights Reserved -
Send this to a friend